Artificial Intelligence in Model‐Informed Drug Development: Augmentation, Acceleration, and Regulatory Preparation
Hao Zhu, Ruihao Huang, Menglun Wang, Lixia Zhang, Hanrui Zhang, Yutao Gong, Rajnikanth Madabushi, Qi Liu · 2026
Read Artificial Intelligence in Model‐Informed Drug Development: Augmentation, Acceleration, and Regulatory Preparation by Hao Zhu, Ruihao Huang, Menglun Wang, Lixia Zhang, Hanrui Zhang, Yutao Gong, Rajnikanth Madabushi, Qi Liu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13550507.txt.
Description
Hao Zhu, Ruihao Huang, Menglun Wang, and five colleagues survey AI entering model-informed drug development in this two thousand twenty-six paper. Such development already uses math frameworks to guide dosing and proof gathering. The authors argue AI is a next step for that toolbox. It can tackle hard data merging, complex biology, and limits that strain older methods. AI can augment set models in hybrid approaches and extend development into new model types. Recent regulator guidance, they note, shows agencies preparing to accept AI within this framework.
Catalog record
| CREATOR | Hao Zhu, Ruihao Huang, Menglun Wang, Lixia Zhang, Hanrui Zhang, Yutao Gong, Rajnikanth Madabushi, Qi Liu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 13 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |